Hyun-Soo Lee
Direktor/Vorstandsmitglied bei APROGEN MEDICINES INC.
Aktive Positionen von Hyun-Soo Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APROGEN MEDICINES INC. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| Seoul National University | Corporate Officer/Principal | - | - |
| The National Academy of Engineering of Korea | Corporate Officer/Principal | 01.01.2012 | - |
| Korea Association of Procurement & Supply Management | Präsident | 01.01.2011 | - |
| Pharosvaccine | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Hyun-Soo Lee
Ehemalige bekannte Positionen von Hyun-Soo Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Architectural Institute of Korea | Präsident | 01.01.2018 | 01.01.2020 |
| Korea Facility Management Association | Präsident | 01.01.2009 | 01.01.2010 |
| Korea Institute of Construction Engineering & Management | Präsident | 01.01.2007 | 01.01.2009 |
Celltrion, Inc. /Old/
 Celltrion, Inc. /Old/ BiotechnologyHealth Technology Celltrion, Inc. manufactures biomedical and pharmaceutical products. It manufactures therapeutic monoclonal antibodies and recombinant proteins. The company was founded in 2002 and is headquartered in Inchon, South Korea. | Corporate Officer/Principal | 01.01.2002 | 02.09.2008 |
| ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - | |
| ░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░ ░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Hyun-Soo Lee
| University of Michigan | Doctorate Degree |
| Seoul National University | Graduate Degree |
Statistik
International
| Südkorea | 13 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 4 |
| President | 4 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SAMSUNG C&T CORPORATION | Industrial Services |
| APROGEN MEDICINES INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Celltrion, Inc. /Old/
Celltrion, Inc. /Old/ BiotechnologyHealth Technology Celltrion, Inc. manufactures biomedical and pharmaceutical products. It manufactures therapeutic monoclonal antibodies and recombinant proteins. The company was founded in 2002 and is headquartered in Inchon, South Korea. | Health Technology |
Samyang Genex Corp.
 Samyang Genex Corp. Agricultural Commodities/MillingProcess Industries Samyang Genex Corp. engages in the manufacture of starches and glucose or maltose. Its products include glucose, starch syrup, fructose, general starch, modified starch, sorbitol, maltitol, and oligosaccharides. The company was founded on April 3, 1964 and is headquartered in Seoul, South Korea. | Process Industries |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| The National Academy of Engineering of Korea | |
| Architectural Institute of Korea | |
| Korea Association of Procurement & Supply Management | |
| Korea Facility Management Association | |
| Korea Institute of Construction Engineering & Management | |
| Pharosvaccine |
- Börse
- Insiders
- Hyun-Soo Lee
- Erfahrung
